Sign in
SENS Stock Price, Chart, Stats & News
Senseonics Holdings, Inc.
Save
Senseonics Holdings, Inc. (SENS) does not currently pay a dividend.
425.46M
Market cap
–
Current P/E
21.01x
Forward P/E
SENS chart
Fundamentals
Gross margin | 44.96% |
Operating margin | -184.89% |
Pretax margin | -189.91% |
Net margin | -189.91% |
Effective tax rate | – |
ROA | -55.51% |
ROE | -104.17% |
D/E | 0.68x |
Interest coverage ratio | -5.42x |
SENS valuation
P/E | – |
P/S | 7.42x |
P/B | 4.48x |
P/CF | -4.27x |
P/FCF | -4.21x |
P/OCF | -4.27x |
PEG | 1.77x |
EV multiple | -5.11x |
About
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices.
Similar securities
Based on sector and market capitalization
Report issue